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The output of a nebulizer is generally defined as its weight loss during 1 min of nebulization. This mass output
includes the weight loss due to evaporation of the solution required to moisten the dry air that is fed through the
nebulizer. In order to compare results obtained from studies using dierent nebulizers we introduce the salt output
as the amount of the solution that actually leaves the liquid phase as droplets and not by evaporation.
The performance characteristics of a standard jet nebulizer (MA2) and a Sidestream jet neublizer were compared.
Mass output was determined at dierent methacholine concentrations. Salt output was assessed by analysing the
remaining salt in the nebulizers after 1 min of nebulization. Overall system performance in terms of forced
expiratory volume in 1 sec (FEV1) reduction after 1 min of exposure to individually selected concentrations of
methacholine were studied in 15 healthy, non-smoking subjects.
Both nebulizer types showed a moderate linear increase of mass output with methacholine concentration. The
eciency coecient, the quotient between salt output and mass output, was found to be 0?93 and 0?75 for the MA2
and Sidestream nebulizer respectively. These findings were explained by dierences in airflow through, and
temperature inside, the nebulizers. The salt output of the nebulizers proved to be better correlated to the FEV1-
reduction following methacholine inhalation than did the mass output. The relative amount of the salt output that
adhered to the acrylic walls of the Sidestream nebulizer drying tower was found to be 9%.
We conclude that it is more appropriate to use salt output than mass output as a nebulizer performance
descriptor. The study also shows the importance of determining nebulizer system performance under conditions as
similar to true provocations as possible.
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Methacholine provocation is well established method of
evaluating the responsiveness of human airways. The
bronchial provocation is often performed by inhaling
increasing doses of methacholine until a certain reduction
of FEV1 is observed. Methacholine is administered by
means of nebulizer, which produces an inhalable aerosol
from a solution (1–3).
To calculate the administered methacholine dose the
output of the nebulizer has to be known. The output is
normally expressed as the weight loss of the nebulizer
content during 1 min of nebulization. Because of an
evaporative weight loss there is no clear relation between
the dose of methacholine administered to the airways of a
subject and the weight loss of the nebulizer content (3–5).
The air which is used to nebulize the solution reaches full
saturation with water while passing through the nebulizer.
This means that water will be removed from the solution in
excess of the solution nebulized. This results in an increased
methacholine concentration of the remaining solution, andReceived 10 May 1999 and accepted 3 September 1999.
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0954-6111/00/020139+06 $35?00/0a weight loss (mass output, Outmass) that is larger than the
weight of the nebulized methacholine solution (salt output,
Outsalt). Factors influencing the outcome in this respect are
dryness and flow of air and temperature of the solution.
Thus, when results from studies where nebulizers with
dierent physical characteristics are compared (6), defining
the output by weight loss is not sucient.
The aim of the present study was to provide a method
which makes it possible to compare bronchial methacholine
challenges performed with dierent nebulizers. By defining
the salt output of a jet nebulizer (MA2) and the Sidestream
jet nebulizer and by focusing on the mass output and
output eciency of the nebulizer systems the amount of
methacholine which is deposited in airways is estimated.
Biological eects are also studied in order to evaluate the
‘‘overall system performance’’.
Methods and materials
NEBULIZERS AND DRYING DEVICES
A modified methacholine provocation test was designed to
study changes in bronchial responsiveness for example,
environmental occupational exposure in healthy subjects.# 2000 HARCOURT PUBLISHERS LTD
140 L. EKLUND ET AL.A jet nebulizer (MA2) and a Sidestream jet nebulizer
were compared (see below). The nebulizers were attached to
drying devices of dierent shapes, a jet cone and a
Sidestream tower as shown in Fig. 1 and 2. (7). The two
drying devices had the same volume (3.4 l) and served the
purpose of allowing droplets of the aerosol to evaporate
(during approximately 8.5 sec). This procedure leads to an
output of a more respirable methacholine aerosol from the
system (8). Dry air was used both to produce the aerosol
and to serve as drying air in both nebulizer systems. Both
systems produce a constant airflow of 24 l min71 (0.4 l s71)
to be inhaled by the subject. All flows were measured using
a Fischer & Porter 10A 3200 rotameter (Horsham, Pa,
U.S.A.).
The jet cone uses a MA2 jet nebulizer (Viasol marketing,
Bunkeflostrand, Sweden) (19). The aerosol is produced by
passing compressed air (pressure 390 kPa) through the
nebulizer. This produces an airflow of 6l min71. Additional
air, 18 l min71, is fed into the system at the top of the
drying tower in order to produce the desired total airflow ofFIG. 2. The Sidestream tower nebulizer system.
FIG. 1. The jet cone nebulizer (MA2) system.24 l min71. The mouth-piece is located at the lower end of
the stainless steel drying device (8). One specimen of this
nebulizer type was used for all tests.
The Sidestream tower uses a Sidestream type 1200
nebulizer (Medic-Aid, Pagham, U.K.) to which compressed
air (pressure 160 kPa) is supplied which produces an airflow
of 9 l min71. In standard operation the output of this
nebulizer is enhanced by the Venturi eect which sucks
ambient air into the nebulizer. In the present application,
however, a controlled flow of 15 l min71 is fed into the
nebulizer through the Venturi opening in order to maintain
stable conditions and a total flow of 24 l min71. The
aerosol produced in the nebulizer propagates up through an
acrylic cylinder to the mouth-piece at its top.
NEBULIZER OUTPUT
When determining the output of the two systems, the
nebulizer was filled with 3 ml of the saline solution (9). The
mass output measured as the weight loss of the nebulizer
during 1 min of nebulization, will over-estimate the amount
of salt that has left the nebulizer as the weight loss partly
will be due to evaporation of water. We therefore
introduced the salt output as an estimate of the dose
equivalent output. The salt output is the amount of the
original solution that contains the same amount of salt that
does actually leave the nebulizer during the first minute of
nebulization. The eciency coecient of the nebulizer, Ke,
is defined as
Keff  Outsalt=Outmass
The eects of methacholine concentration on mass
output was determined for both nebulizers. Three concen-
trations (0, 32 and 64 mg min71, corresponding to total
molar salt concentrations of 154, 318 and 481 mM) of
methacholine in saline were used. Ten nebulizations were
made for both nebulizers at all concentrations. Environ-
mental conditions were identical for all series.
The maximal amount of water that could evaporate from
the solution during nebulization was calculated. Since dry
air was used as input, and assuming that the air that leaves
the nebulizer is saturated with water, the maximal
evaporation depends only on the airflow and the tempera-
ture inside the nebulizer.
During nebulization of saline with both nebulizers,
temperature was measured using a K-type thermocouple
probe placed inside the nebulizer chamber. The tempera-
ture was read using a TES 1310 instrument (TES, Taipei,
Taiwan).
MEASUREMENTS OF SALT OUTPUT
A device was designed to measure the saline concentration
of the remaining solution in the nebulizer by measuring its
impedance. A 0?5 ml sample of the solution to be tested was
put in a 1?5 ml Eppendorf plastic test tube (Tre AG,
Degershaim, Switzerland). A probe consisting of two gold
plated electrodes protruding from the end of a silicone
rubber sealed, plastic tube was submerged into the solution
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series with a 300 resistor and a 5.0 kHz (sinus), 30 mV Rms-
voltage was applied by a function generator (Topward TFG
8101, Taipei, Taiwan). Voltage was measured over the
resistor and the probe respectively using a multimeter
(Fluke 79, Everett, WA, U.S.A.). The impedance of the
sample was calculated. When used in a standardized
manner including thorough cleaning in between measure-
ments, the device produced reproducible results in the
saline concentration range 1075% to 2%.
A relationship between impedance and saline concentra-
tion was determined by analysing 20 series of known saline
concentration in the range 0.5–2%. A third degree
polynomial was fitted to data describing the impedance
relative to the impedance at the concentration of 1%.
Twelve nebulizations were made using the single jet
nebulizer. Three nebulizations were made with each of four
Sidestream jet nebulizers. Mass output was determined by
weighing. Three samples were taken out of the remaining
solution from each nebulization. For each sample a
matching control sample was taken out of the original
1% saline solution. Saline concentrations were determined
using the previously described technique.
Neublizations and analyses were made under controlled
climatic conditions with an ambient temperature of
20?2–29?98C (10). Solutions were brought to room tem-
perature before nebulization. A protocol of alternating
orders designed to minimize order bias was used.
The salt output was calculated from the equation
describing the conservation of salt through the nebulization
process:
Outsalt  Cb  Vb CbÿVa Ca
where Vb and Cb and Va and Ca are the volumes and saline
concentrations of the solution before and after nebulization
respectively.
Measurements of salt output was carried out using saline
solutions without methacholine. It was assumed that the
basic process of moistening the air by evaporation from
droplets and the solution is not largely aected by the
methacholine concentration.
BIOLOGICAL EFFECTS
Fifteen healthy never-smokers (eight females), mean age
39.5 years (range 25–50), participated in this part of the
study. The airway responsiveness was tested with both
nebulizer systems in all subjects. Conditions were standar-
dized with regard to ambient temperature (19?5–21?08C)
(10), time of the day and eating and drinking prior to the
test. The interval between the two provocations was at least
1 day. Eight subjects started with the jet cone and seven
with the Sidestream tower. Three FEV1 (with a dierence of
5%), measured with a wedge spirometer (Vitalograph1,
Buckingham, U.K.), were recorded at least 20 min prior to
the methacholine provocation. The best FEV1 was used as
pre-challenge baseline. Methacholine was inhaled during 1
min and a metronome (15 breaths min71) was used to pace
breathing (11,12). The concentration of methacholine waschosen individually (4–64 mg ml71) according to previous
tests to produce at least a 20% reduction of FEV1. A single
FEV1 was monitored 4 min after the start of the methacho-
line inhalation, when the maximal eect of the methacho-
line could be anticipated (1). The dierence in biological
eect between the two systems was evaluated both with and
without respect to mass output and salt output of the
nebulizers. The project was approved by the ethics
committee at the Karoliska Institute and all subjects gave
their informed consent.
DATA ANALYSIS
All statistical and mathematical calculations were per-
formed using MS-Excel 5.0 for the PC and CricketGraph
1.3.2 for the Macintosh computer. Student’s t-tests, curve-
fits based on the least square method and equation solving
by means of iteration were performed. Statistical dierences
have been considered significant at a P-value 50?05. Data
are expressed as mean (standard deviation).
Results
All results refer to 1 min of nebulization. A summary of
nebulizer data and results is presented in Table 1. The MA2
jet nebulizer produced a mass output of 0426 (0035) g
when operated with 1% saline under normal conditions.
The corresponding value for the Sidestream nebulizer was
0623 (0035) g. Both nebulizers proved to have a linear
increase in mass output with increasing methacholine
concentrations (Fig. 3). The relative increase over the
whole range was 9 and 8% for the MA2 and Sidestream
nebulizer, respectively. The corresponding slopes were 014
and 013% per mg ml71.
The Initial temperature in the nebulizers was 2008C and
the room temperature varied between 195–210. The liquid
of the nebulizer undergoes a temperature drop as energy is
required in the process of evaporation. The temperature in
the MA2 nebulizer dropped to 1618C after 1 min of
nebulization. The temperature in the Sidestream nebulizer
dropped more rapidly and reached 148C in 15 sec and was
998C after 1 min of nebulization.
The maximal evaporation to the air passing through the
systems was calculated by integrating the temperature
dependent water uptake over one minute of nebulization.
When saturated, 6 l of air which is fed through the MA2
nebulizer can hold at most 0092 g of water. The
corresponding figure for the 24 l of air passing through
the Sidestream nebulizer is 0276 g.
The concentration of the remaining saline solution after
nebulization increased to 1012 (0040)% with the jet
nebulizer. The corresponding value with the Sidestream
nebulizer was 1065 (0044) %. The salt output was 0394
(0105) g with the MA2 nebulizer and 0469 (0120) g with
the Sidestream nebulizer.
The eciency coecient from the experimental from the
experimental data was 0928 (0247) for the MA2 jet
nebulizer and 0750 (0172) for the Sidestream jet nebulizer.
TABLE 1. Summary of nebulizer data
MA2 jet
nebulizer
Sidestream type 1200 jet
nebulizer
Drying device 34 l steel cone 34 acrylic cylinder
Primary air through nebulizer (l min71) 6 9
Drying air supply (l min71) 18
(into top of steel cone)
15
(into Venturi opening of the nebulizer)
Mass output using 1% saline (g) 0426 (0035) 0623 (0035)
Mass output vs. methacholine concentration
(% l mg ml71)
014 013
Temperature drop (C8) From 200 to 161 From 200 to 99
Estimated maximal water requirement to
humidify nebulizer air (g)
0092 0276
Salt output using 1% saline (g) 0394 (0105) 0469 (0120)
Eciency coecient 0928 (0247) 0750 (0172)
Relative amount of salt output remaining in
drying device (%)
– 93
FEV1 reduction (%) 39 (15) 34 (14)
FEV1 reduction corrected for salt output (% g
71) 100 (41) 82 (37)
FEV1 reduction corrected for mass output (% g
71) 93 (38) 62 (28)**
All data refers to 1 min nebulizations using room-temperature solutions. Data presented as mean values (SD). **P5001 when
comparing the two nebulizer types.
FIG. 3. Mass output as a function of the methacholine
FIG. 4. Change in FEV1 normalized for mass output and
salt output. Horizontal lines indicate mean values.
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jet cone well enough to accurately determine the amount of
salt deposited in that drying device.
The Sidestream tower was easier to clean and the saline
concentration of the rinse water was found to be 7461075
% before and 9261074 % after nebulization. The salt
deposited amounted to 93% of the salt output of the
Sidestream nebulizer.
BIOLOGICAL EFFECTS
The methacholine provocation performed with the jet cone
reduced FEV1 by 39 (15)%. The corresponding reduction
using the Sidestream tower was 34 (14)% (P=0182).
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salt output. The eect per salt output unit was 100(41)%
g71 for the Sidestream tower (P=0097).
The reduction of FEV1 for the subjects was also
normalized by dividing it by the mass output. The jet cone
had a significantly higher eect per mass output unit had
the Sidestream tower, 93 (38) compared to 62 (28)% g71
(P=0003) (Fig. 4).
Discussion
For both clinical and research purposes bronchial chal-
lenges have been used to evaluate airway responsiveness for
a considerable time. Methods and nebulizer systems have
successively been improved to enable an eective nebuliza-
tion, good deposition in the airways and reproducible
results. Still there may be a large variability between units
of the same kind (13,14). Systems used may also dier in
terms of, for example overall design, physical work
principles of the aerosol production, (mass) output, particle
size distribution, aerosol drying or breathing control.
Studies of these factors are important to enable compar-
isons of data obtained with dierent systems (2, 15–18). In
the present study it has been demonstrated that the mass
output from the Sidestream jet nebulizer is 46% higher than
for the MA2 jet nebulizer when operated with 1% saline.
However, when comparing salt output the Sidestream
nebulizer only yields 19% higher output compared with
the MA2 jet nebulizer. From these results it is quite clear
that comparisons between airway responsiveness data
obtained by dierent challenge systems have to consider
nebulizer salt output. A ‘traditional’ approach to evaluate
measurements made with two dierent nebulizer systems
would be to study the FEV1-reduction per mass output
unit. In the present study this approach resulted in a highly
significant dierence between the two systems (P=0003)
although the biological eect (FEV1-reduction) itself, did
not dier between the two systems. By relating the FEV1-
reduction to salt output no significant dierence was found
between the two nebulizer systems. This approach thus
seems to be in better accordance with the biological eects.
The increase of concentration found in the remaining
solution after 1 min of nebulization was approximately 1%
for the MA2 nebulizer and 65% for the Sidestream jet
nebulizer. The progressive concentration increase and the
decreasing output rate during prolonged nebulization
emphasises the importance of not extrapolating the results
in this study to exposure times longer than 1 min. Salt
output should be determined by a procedure similar to the
one used for provocation.
If the salt output was the only descriptor of overall
nebulizer system performance one would expect to find no
dierence in the biological eect per unit salt output
between the two systems. However, there is a tendency of a
greater biological eect per unit salt output for the jet cone
than for the Sidestream tower and there are possible
explanations for this. Our tests show that approximately
90% of the methacholine nebulisate produced with the
Sidestream tower actually leaves the drying device. Forreasons of static electricity, it is likely that the aerosol
would be less prone to adhere to the walls of the steel cone
than to the acrylic walls of the Sidestream tower (19,20).
This would promote a greater eect per unit salt output for
the former device. There may also be dierences in the
particle size distribution or drying properties of the
nebulizer systems. According to the manufacturer the mass
median diameter (MMD) of the Sidestream nebulizer is
275 mm when operated at 8 l min71. When operated 9 l
min71 as in the present study the MMD is likely to be
slightly smaller, 17 (13) mm, resulting in less eective lung
deposition (9).
Measurements of mass output are in general done using
saline which is regarded to be reasonably valid also for
other solutions, for example methacholine. In the present
study the mass output increased linearly over the concen-
tration range used for provocations for both types of
nebulizers. However, as the relative increase of mass output
is modest and about the same for both nebulizer types this
can be disregarded, especially when comparing eects from
exposures of the same nominal concentrations. Methods to
measure solute output from a nebulizer using a solute
chemical tracer and impact aerosol onto filters have been
described (21). However, we have chosen a more simple
method by determining the salt concentration of the
remaining solution in the nebulizer, by measuring its
impedance.
The eciency coecient is a measure of the eciency of
the weight loss during nebulization. The interpretation of
an eciency coecient of 1 (salt output is equal to mass
output) is that no water is taken from the solution to
moisten the air that passes through the neublizer. The other
extreme would be if all the dry air that passes through the
nebulizer was saturated with water taken from the solution.
With the mass outputs and the calculated maximal water
uptake in the present study, this would correspond to an
eciency coecient of 078 for the MA2 nebulizer and 056
for the Sidestream jet nebulizer. The moderate flow through
the MA2 nebulizer promotes a relatively high value, despite
its higher average temperature. With the Sidestream
nebulizer a larger flow promotes a lower value, despite its
lower temperature. The eciency coecients obtained from
the experimental data, 093 and 075 for the MA2 and
Sidestream nebulizers, respectively, are well above the
calculated lower limits. The main reason for this is that
some of the water used for moistening the air is taken from
aerosol droplets that eventually will leave the nebulizer,
thereby reducing the uptake from the solution itself. A
higher experimental eciency coecient would also be
promoted if air leaving the nebulizer is not completely
saturated because of the short time (approximately 30 msec
for the Sidestream nebulizer) it resides in the humid
nebulizer environment.
In conclusion, knowing the performance characteristics
of nebulizer systems is important, especially when dierent
systems are used to determine airway responsiveness. This
study shows that the salt output of the nebulizer used for
aerosol production is better correlated to the biological
eects than is the mass output. Findings of increasing mass
output with methacholine concentration and the amount of
144 L. EKLUND ET AL.salt adhering to the drying device show that these factors
should be considered when designing methods and devices
for provocation tests especially important for scientific
purpose. System performance should be determined under
conditions as similar to true provocations as possible.
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